Pharma-Bio Serv, Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2021
September 14, 2021 at 04:07 pm EDT
Share
Pharma-Bio Serv, Inc. announced earnings results for the third quarter ended July 31, 2021. For the third quarter, the company announced sales was USD 4.987 million compared to USD 6.278 million a year ago. Operating income was USD 360,490 compared to USD 816,690 a year ago. Net income was USD 2.275 million compared to USD 692,114 a year ago. Basic earnings per share from continuing operations was USD 0.098 compared to USD 0.03 a year ago. For the nine months, sales was USD 14.517 million compared to USD 16.539 million a year ago. Operating income was USD 944,390 compared to USD 2.073 million a year ago. Net income was USD 2.783 million compared to USD 1.906 million a year ago. Basic earnings per share from continuing operations was USD 0.12 compared to USD 0.083 a year ago.
Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The Company provides a range of compliance-related consulting services. The Company provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The Company's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.
PHARMA-BIO SERV, INC. 
